-- Sanofi says FDA accepts filing for new diabetes drug Toujeo
-- 
-- Tue Jul 08, 2014 01:07AM EDT
-- None



PARIS, July 8 (Reuters) - Sanofi <SASY.PA> said on Tuesday the U.S. Food and Drug Administration had accepted  for review the filing of a new drug application for its diabetes drug Toujeo.

"With the FDA's acceptance of our submission, we are anticipating the regulatory decision for marketing authorization for Toujeo in the U.S. in the first half of 2015." said Pierre Chancel, Senior Vice President, Global Diabetes at Sanofi.